; 34: 220?33. PMID: 8628042 Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005; 113: 9?9. PMID: 15621359 Haythornthwaite JA, Fauerbach JA. Assessment of acute pain, pain relief, and patient satisfaction. In: Turk DC, Melzack R, editors. Handbook of Pain Assessment ( 2nd Ed). New York: Guilford Press; 2001. Jensen MP. The Validity and Reliability of Pain Measures for use in Clinical Trials in Adults: Review Paper Written for the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) meeting, April 12?3. 2003. Birnie KA, McGrath PJ, Chambers CT. When does pain matter? Acknowledging the subjectivity of clinical significance. Pain. 2012; 153: 2311?314. doi: 10.1016/j.pain.2012.07.033 PMID: 22995250 Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The Journal Of Pain: Official Journal Of The American Pain Society. 2008; 9: 105?21. PMID: 18055266 Farrar JT, Young JPJ, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001; 94: 149?58. PMID: 11690728 Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000; 88: 287?94. PMID: 11068116 Mucchielli R. Analyse de contenu des documents et des communications. France: ESF; 2006. Geisser ME, Clauw DJ, Strand V, Gendreau RM, Palmer R, Williams DA. purchase GSK-1605786 Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain (03043959). 2010; 149: 373?78. doi: 10.1016/j.pain.2010. 02.043 PMID: 20332060 Hudson JI, Arnold LM, Bradley LA, Choy EH, Mease PJ, Wang F, et al. What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine. The journal of Rheumatology. 2009; 36: 2517?522. doi: 10.3899/Belinostat mechanism of action jrheum.090139 PMID: 19833743 H ser W, Bernardy K, U yler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA: The Journal Of The American Medical Association. 2009; 301: 198?209. doi: 10.1001/jama.2008.944 PMID: 19141768 Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ. Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain (03043959). 2010; 149: 360?64. doi: 10.1016/j.pain.2010.02.039 PMID: 20347225 Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, et al. Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Annals of the Rheumatic Diseases. 2004; 63: 290?96. PMID: 14962965 Busch AJ, Thille P, Barber KAR, Schachter CL, Bidonde J, Collacott BK. Best practice: E-Model–prescribing physical activity and exercise for individuals with fibromyalgia. Physiotherapy Theory Practice. 2008; 24: 151?66. Brosseau L, Wells GA, Tugwell P, Egan M, Wilson KG, Dubouloz C, et al. Ottawa Panel evidencebased clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Ph.; 34: 220?33. PMID: 8628042 Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005; 113: 9?9. PMID: 15621359 Haythornthwaite JA, Fauerbach JA. Assessment of acute pain, pain relief, and patient satisfaction. In: Turk DC, Melzack R, editors. Handbook of Pain Assessment ( 2nd Ed). New York: Guilford Press; 2001. Jensen MP. The Validity and Reliability of Pain Measures for use in Clinical Trials in Adults: Review Paper Written for the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) meeting, April 12?3. 2003. Birnie KA, McGrath PJ, Chambers CT. When does pain matter? Acknowledging the subjectivity of clinical significance. Pain. 2012; 153: 2311?314. doi: 10.1016/j.pain.2012.07.033 PMID: 22995250 Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The Journal Of Pain: Official Journal Of The American Pain Society. 2008; 9: 105?21. PMID: 18055266 Farrar JT, Young JPJ, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001; 94: 149?58. PMID: 11690728 Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000; 88: 287?94. PMID: 11068116 Mucchielli R. Analyse de contenu des documents et des communications. France: ESF; 2006. Geisser ME, Clauw DJ, Strand V, Gendreau RM, Palmer R, Williams DA. Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain (03043959). 2010; 149: 373?78. doi: 10.1016/j.pain.2010. 02.043 PMID: 20332060 Hudson JI, Arnold LM, Bradley LA, Choy EH, Mease PJ, Wang F, et al. What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine. The journal of Rheumatology. 2009; 36: 2517?522. doi: 10.3899/jrheum.090139 PMID: 19833743 H ser W, Bernardy K, U yler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA: The Journal Of The American Medical Association. 2009; 301: 198?209. doi: 10.1001/jama.2008.944 PMID: 19141768 Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ. Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain (03043959). 2010; 149: 360?64. doi: 10.1016/j.pain.2010.02.039 PMID: 20347225 Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, et al. Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Annals of the Rheumatic Diseases. 2004; 63: 290?96. PMID: 14962965 Busch AJ, Thille P, Barber KAR, Schachter CL, Bidonde J, Collacott BK. Best practice: E-Model–prescribing physical activity and exercise for individuals with fibromyalgia. Physiotherapy Theory Practice. 2008; 24: 151?66. Brosseau L, Wells GA, Tugwell P, Egan M, Wilson KG, Dubouloz C, et al. Ottawa Panel evidencebased clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Ph.
